QRxPharma Limited

ABN 16 102 254 151

Annual report for the year ended 30 June 2016 QRxPharma Limited ABN 16 102 254 151 Annual report - 30 June 2016 Contents

Page

Corporate directory 1

Letter from the Board 2

Directors' report 3

Auditor's Independence Declaration 15

Corporate governance statement 16

Financial report 23

Directors' declaration 50

Independent auditor's report to the members of QRxPharma Limited 51

Shareholder information 53

QRxPharma Limited

30 June 2016

Corporate directory

Directors

Richard S Treagus BScMed, MBChB, MPharmMed, MBA

Bruce A Hancox BCom

Secretary

Chris J Campbell CA

Principal registered office in Australia

QRxPharma Limited

Level 11, Suite 1

100 Walker St

North Sydney NSW 2060

Share register

Link Market Services Limited

Level 12

680 George Street

Sydney NSW 2000

Auditor

Deloitte Touche Tohmatsu

Eclipse Tower

60 Station street

Parramatta

NSW 2150

Bankers

Westpac Banking Corporation

Level 9 Keycorp Tower

799 Pacific Highway

Chatswood NSW 2067

Silicon Valley Bank

3003 Tasman, Santa Clara

California 95054

U.S.A.

Stock exchange listings

QRxPharma Limited shares are listed on the Australian Securities Exchange. Listing Code: QRX

QRxPharma Limited American Depositary Receipts are listed on the OTC Pink Current. Symbol: QRXPY

Website address

www.qrxpharma.com

QRxPharma Limited 30 June 2016 Letter from the Board

Letter from the Board

Dear Shareholder,

The key events throughout this year have been as follows:

  • 30 November 2015 - the creditors of the Company voted in favour of a Deed of Company Arrangement (DOCA) which was executed on 8 December 2015.

  • 23 December 2015 - the DOCA was wholly effectuated on 23 December 2015 returning the management and control of the Company to the Board.

  • 19 May 2016 - the Company held its 2015 Annual General Meeting and Dr Richard S Treagus was re-elected as a director of the Company.

The Directors are presently addressing compliance matters with a view to enabling the reinstatement of the Company's securities to official quotation on the ASX in the near future.

We thank you for your patience and we look forward further updating shareholders during 2016.

Sincerely,

Dr Richard S Treagus Non-Executive Director

Mr Bruce A Hancox Non-Executive Director

QRxpharma Ltd. published this content on 24 October 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 24 October 2016 00:02:01 UTC.

Original documenthttp://www.qrxpharma.com/irm/PDF/1533/AnnualReport2016

Public permalinkhttp://www.publicnow.com/view/0F4AE9F325EB779361B5142C1A1144E3BEFD9DBF